InterValley Ventures is an early stage Venture Capital Fund investing in breakthrough technologies. The AI^Human fund focuses on companies that generate, control and learn from unique data sources. Sectors include Healthcare, Life Sciences, Space, AgTech, FoodTech, FinTech, Supply Chain and EduTech. To date InterValley has completed 12 investments across a range of technologies. Our focus includes companies with technologies that improve AI performance and companies with hardware applications, including robotics, computer vision, sensor networks and drones. We also look generally at companies that have new, AI-enabled business models that are transforming industries and addressing global problems - 80% of our capital will be deployed in Australia. Australian AI is World Class. The universities are amongst the very best and the are many excellent start up companies and inspiring founders. These companies often receive large non-dilutionary grants & rebates. InterValley places significant importance on the character, values and ambitions of the Founders it works with - seeking a collaborative partnership approach in its investments. The AI^Human fund is globally backed by Japanese & other firms who are providing a combined anchor of $A30M, with a target fund size of $A100M. The multinational anchors value the rapid growth strategy of the fund: companies that are US similar, with attractive valuations, access to the very best deals, Japanese uplift, Asian uplift, and global exits. InterValley is strengthened by having New Frontier Capital Management as co-GP. NFCM is the strategic partner for Mizuho Securities PE Business with global reach.